DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 3NanoAlvand
03 1Octavius Pharma Pvt. Ltd
04 15Pharmathen SA
05 9Strides Pharma Science
06 272care4
07 6AMN Life Science
08 11Abacus Medicine
09 24Accord healthcare
10 4Adcock Ingram
11 3Ajanta Pharma Limited
12 3Akriti Pharmaceuticals Pvt. Ltd.
13 3Alkem Laboratories
14 8Alphapharm PTY Ltd
15 6Aps-Arzneimittel-Parallelimport-Service Ag
16 12Arrow Pharmaceuticals
17 4Ascent Innovative Medicines
18 135Astellas Pharma
19 1Avet Pharmaceuticals
20 3Biocon
21 2Boston Pharma
22 3CHENGDU
23 6CHIESI USA INC
24 2Cantabria Labs
25 19Chiesi Group
26 1Chongqing Huapont Pharmaceutical
27 3Cinfa
28 3Cipla Medpro South Africa
29 3Concord Biotech
30 2Dermapharm Holding
31 2Difa Cooper
32 4EG Spa
33 2EQL Pharma
34 25Ebb Medical
35 2Eldroga
36 1Encube Ethicals
37 3Endo International
38 1Epione Medicine Aps
39 2Farmagon
40 2Farmatek
41 3Finno Medical Limited
42 4Focelite
43 2Fougera Pharmaceuticals Inc.
44 1Galenica Ab
45 1Galenicum
46 5Glenmark Pharmaceuticals
47 3Hangzhou Zhongmei Huadong Pharmaceutical
48 1Hospira, Inc.
49 1Indiana Ophthalmics
50 7Intas Pharmaceuticals
51 3Ivax Scandinavia Ab
52 3Jiangsu Hengrui Medicine
53 3Karo Pharma
54 28Leo Pharma
55 4Madras Pharmaceuticals
56 41Medartuum
57 3Medipol Pharmaceutical
58 3Murli Krishna Pharma
59 3Naprod Life Sciences
60 1Nexus Pharmaceuticals
61 1Norameda
62 2Nordic Prime Aps
63 2Northern Medical Group Aps
64 79ORIFARM GROUP AS
65 2Omnia Mutantur Pharmaceuticals Ab
66 9Panacea Biotec Limited
67 2Paranova Group AS
68 30Paranova Pharmaceuticals Ab
69 9Pharmachim Ab
70 12Pharmacore Inc
71 3Pierre Fabre
72 3Pinnacle Life Science
73 3RPG Life Sciences
74 1SKNV
75 12STADA Arzneimittel
76 110Sandoz B2B
77 2Smith & Kenner Pharmaceuticals
78 38Teva Pharmaceutical Industries
79 11Unimedic AB
80 1United Biotech
81 3Veloxis Pharmaceuticals
82 6Viatris
83 2West-Coast Pharmaceuticals
84 3World Medicine
85 3XYZ Pharma
01 30CAP
02 4CAPSULE
03 7CAPSULE (EXTENDED RELEASE)
04 6CAPSULE (IMMEDIATE RELEASE)
05 6CAPSULE, EXTENDED RELEASE;ORAL
06 40CAPSULE;ORAL
07 307Capsule
08 9Capsules
09 3Caspule
10 1Concentrate For Infusion Solution
11 4Concentrate For Solution For Infusion
12 2Cream
13 1Cutaneous Emulsion
14 3ER Capsule
15 4Extended Release Capsule
16 4Extended Release Capsules
17 1Extended Release Hard Capsules
18 1Extended Release Tablet
19 22Extended-Release Hard Capsule
20 7Extended-Release Tablet
21 4Eye Ointment
22 2FOR SUSPENSION;ORAL
23 15Granule For Oral Suspension
24 20Hard Capsule
25 17Hard Capsules
26 6Hard Capsules With Extended Release
27 1Hard Capsules With Extended Release-Oral
28 1Hard Capsules With Prolonged Release
29 4Hard Gelatin Capsule
30 1Hard Release Capsules
31 2Hard Release Capsules - Oral
32 1INJ
33 3INJECTABLE;INJECTION
34 1Injection
35 3Modified Release Capsule
36 1Modified Release Tablet
37 4OIN
38 4OINTMENT
39 9OINTMENT;TOPICAL
40 38Ointment
41 3Oral Solid Dosage Form
42 3Pellets For Capsule
43 1Pellets/Micro pellets for capsules
44 13Prolonged Release Capsule Hard
45 4Prolonged Release Hard Capsule
46 21Prolonged-Release Capsules
47 3Prolonged-Release Tablet
48 1SOLUTION
49 28Salve
50 1Skin Emulsion
51 17Sustained Release Capsule
52 3TABLET (EXTENDED-RELEASE)
53 3TABLET, EXTENDED RELEASE;ORAL
54 14Tablet
55 1Tacrolimus 0.03% 10G Ointment Dermatological Use
56 1Tacrolimus 0.03% 30G Ointment Dermatological Use
57 1Tacrolimus 0.1% 10G Ointment Dermatological Use
58 1Tacrolimus 0.1% 30G Ointment Dermatological Use
59 5Tacrolimus 0.5Mg 30 Joined' Oral Use
60 1Tacrolimus 0.5Mg 30 Joined' Oral Use Rp
61 1Tacrolimus 0.75Mg 30 Joined' Oral Use
62 1Tacrolimus 0.75Mg 30 Joined' Oral Use Rp
63 5Tacrolimus 1Mg 60 Units Oral Use
64 1Tacrolimus 1Mg 60 Units Oral Use Rp
65 1Tacrolimus 1Mg/Die 60 Units Oral Use Rp
66 1Tacrolimus 2Mg 30 Joined' Oral Use
67 1Tacrolimus 3Mg 30 Joined' Oral Use Rp
68 1Tacrolimus 4Mg 30 Joined' Oral Use Rp
69 1Tacrolimus 5Mg 10 Units Parenteral Use
70 4Tacrolimus 5Mg 30 Joined' Oral Use
71 1Tacrolimus 5Mg 30 Joined' Oral Use Rp
72 1Vial
73 56capsule
74 42Blank
01 29Allowed
02 100Approved
03 48Authorized
04 4Cancelled
05 5DISCN
06 169Deregistered
07 22Generic
08 3Lead Market Dossiers- Approved in US
09 3Lead Market Dossiers- Filed
10 25Marketed
11 29Not Marketed
12 14Originator
13 90Prescription
14 58RX
15 3USA
16 239Blank
01 3ACH-TACROLIMUS
02 3ADOPORT
03 4ADVAGRAF
04 16ADVAGRAF XL
05 4ADVAGRAPH
06 3ASTAGRAF XL
07 31Adoport
08 3Adport
09 30Advagraf
10 1Advagraf 0,5 mg
11 1Advagraf 1 mg
12 1Advagraf 5 mg
13 4Advagraph
14 34Advertisement
15 2CARELIMUS
16 4CONFEROPORT
17 2Cellmune
18 5Conferoport
19 5Crilomus
20 40Dailiport
21 1ELTACRO - 0.5mg
22 1ELTACRO - 1
23 3ENVARSUS PA
24 3ENVARSUS XR
25 23Envarsus
26 3Envarsus®
27 1Graftac 0,5
28 1Graftac 0,5 Prolonged Release
29 1Graftac 1
30 1Graftac 1 Prolonged Release
31 1Graftac 5
32 1Graftac 5 Prolonged Release
33 4I Adopt
34 1Lebsanan
35 13Modigraf
36 2Modigraph
37 1Nuju Cream
38 13PROGRAF
39 6PROTOPIC
40 8Pacrolim
41 4Pharmacor Tacrolimus 0.5
42 4Pharmacor Tacrolimus 1
43 4Pharmacor Tacrolimus 5
44 3Pragraf
45 44Prograf
46 2Prograf 0,5 mg
47 2Prograf 1 mg
48 2Prograf 5 mg
49 1Prograf Concentrate for Infusion
50 3Prograft
51 4Program
52 106Prograph
53 18Protopic
54 2Protopic
55 2Protopic 0,03% Ointment
56 2Protopic 0,1% Ointment
57 2Protopic 0.03% Ointment
58 2Protopic 0.1% Ointment
59 2Protopy
60 1Qvaya
61 8Roltisa
62 3SANDOZ TACROLIMUS
63 3SANDOZ TACROLIMUS XR
64 3Suprotac
65 4TACFORIUS
66 1TACIM-0.5 CAPSULE
67 1TACIM-1 CAPSULE
68 3TACNI
69 1TACROLIM 0,03%
70 1TACROLIM 0,1%
71 49TACROLIMUS
72 4TACROLIMUS EG
73 1TACRUM 0,5 mg
74 1TACRUM 1 mg
75 1TACRUM 5 mg
76 2TAKROLADA
77 16Tacforius
78 1Tacgalen
79 24Tacni
80 1Tacrocutan
81 1Tacrocutan g
82 12Tacrograf
83 4Tacrolimus
84 1Tacrolimus 0,5 Teva
85 1Tacrolimus 1 Teva
86 14Tacrolimus 2Care4
87 1Tacrolimus 5 Teva
88 5Tacrolimus Accord
89 3Tacrolimus Actavis
90 1Tacrolimus Carefarm
91 3Tacrolimus Cinfa
92 2Tacrolimus Eql
93 3Tacrolimus IR
94 14Tacrolimus Orifarm
95 2Tacrolimus STADA
96 20Tacrolimus Sandoz
97 2Tacrolimus Stada
98 4Tacrolimus Stadafarma
99 16Tacrolimus XR Sandoz
100 1Tacrolimus "2Care4"
101 3Tacrolimus "Accord"
102 1Tacrolimus "Nordic Prime"
103 1Tacrolimus "Paranova"
104 4Tacrolimus "Stada"
105 5Tacrolus
106 1Tacronova
107 2Takrolimus Abacus Medicine
108 7Takrolimus Accord
109 4Takrolimus Ebb
110 4Takrozem
111 1Takrozem g
112 1Talomune 0,5 mg
113 1Talomune 1 mg
114 1Talomune 5 mg
115 3TarcoPol
116 1Tarograf 0.5
117 1Tarograf 1
118 1Tarograf 5
119 1Tevligraf 0,5
120 1Tevligraf 1
121 1Tevligraf 5
122 64Blank
01 96Australia
02 22Canada
03 4China
04 47Denmark
05 21Estonia
06 7Greece
07 64India
08 3Iran
09 59Italy
10 5Moldova
11 54Norway
12 35South Africa
13 52Spain
14 269Sweden
15 29Switzerland
16 5Turkey
17 1U.S.A
18 63USA
19 2Vietnam
20 3Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Suprotac
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Tacrolimus
Dosage Form : Pellets/Micro pellets for capsules
Dosage Strength : 0.5; 1; 5%; %; %
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : TACROLIMUS
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2014-07-22
Application Number : 90687
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Suprotac
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Suprotac
Dosage Form : Vial
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Roltisa
Dosage Form : Extended-Release Hard Capsule
Dosage Strength : 1MG
Packaging :
Approval Date : 14-10-2022
Application Number : 88195
Regulatory Info : Authorized
Registration Country : Spain
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Roltisa
Dosage Form : Extended-Release Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date : 14-10-2022
Application Number : 88196
Regulatory Info : Authorized
Registration Country : Spain
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Roltisa
Dosage Form : Extended-Release Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date : 14-10-2022
Application Number : 88194
Regulatory Info : Authorized
Registration Country : Spain
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Roltisa
Dosage Form : Extended-Release Hard Capsule
Dosage Strength : 5MG
Packaging :
Approval Date : 14-10-2022
Application Number : 88197
Regulatory Info : Authorized
Registration Country : Spain
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Roltisa
Dosage Form : Prolonged-Release Capsules
Dosage Strength : 0.5mg
Packaging :
Approval Date : 18-08-2023
Application Number : 28106623221
Regulatory Info : Prescription
Registration Country : Denmark
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Roltisa
Dosage Form : Prolonged-Release Capsules
Dosage Strength : 3mg
Packaging :
Approval Date : 18-08-2023
Application Number : 28106623521
Regulatory Info : Prescription
Registration Country : Denmark
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Roltisa
Dosage Form : Prolonged-Release Capsules
Dosage Strength : 5mg
Packaging :
Approval Date : 18-08-2023
Application Number : 28106623621
Regulatory Info : Prescription
Registration Country : Denmark
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Roltisa
Dosage Form : Prolonged-Release Capsules
Dosage Strength :
Packaging :
Approval Date : 18-08-2023
Application Number : 28106623421
Regulatory Info : Prescription
Registration Country : Denmark
